Changes to HLA and unacceptable antigen options in effect
Updates to HLA typing and unacceptable antigen reporting options and equivalencies are now in effect.
Updates to HLA typing and unacceptable antigen reporting options and equivalencies are now in effect.
Effective Sept. 6, OPOs will be required to perform renal procurement biopsies for deceased kidney donors meeting certain criteria.
Several policy changes impacting TIEDI forms were approved by the Office of Management and Budget (OMB) in March 2022.
Effective Aug. 30, new requirements under revisions to OPTN Policy 18: Data Submission Requirements include a data lock provision to make changes to any of the eight TIEDI forms.
Changes to HLA and unacceptable antigen options will go into effect Aug. 30, as well as changes to the equivalences used for HLA matching and screening of unacceptable antigens between candidates and donors.
Transplant hospitals are able to take immediate action to benefit a select population of Black candidates impacted by race-inclusive eGFR calculations.